Global Wellness Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Global Wellness Times.

Press releases published on June 10, 2026

Jun. 10, 2026

GigaCloud Technology Inc to Present at Sidoti Small Cap Conference

Indeterminate GlobeNewswire

Jun. 10, 2026

Fresh From the U.S., BrewDog Unleashes Iconic American Craft Beers Across the U.K.

Indeterminate GlobeNewswire

Jun. 10, 2026

BMGL to Effect Reverse Share Split on June 22, 2026

Indeterminate GlobeNewswire

Jun. 10, 2026

Harrow Re-Launches VERKAZIA® (cyclosporine ophthalmic emulsion) 0.1% for Vernal Keratoconjunctivitis, Addressing Significant Unmet Need in Pediatric Eyecare

Indeterminate GlobeNewswire

Jun. 10, 2026

Planet Fitness Investigation: Planet Fitness (PLNT) Investigated for Misrepresenting its Membership Growth Issues – Contact BFA Law if You Suffered Losses

Indeterminate GlobeNewswire

Jun. 10, 2026

Tilray Medical Germany Launches ARX™, a New Premium Medical Cannabis Brand Cultivated in Germany

Indeterminate GlobeNewswire

Jun. 10, 2026

DeepHealth Launches Reporting Pro, Bringing AI Automation to Radiology Reporting

Indeterminate GlobeNewswire

Jun. 10, 2026

Record-Breaking Sale of Magnificent Lake Tremblant Estate Sets New Benchmark in Québec Luxury Market

Indeterminate GlobeNewswire

Jun. 10, 2026

Italfarmaco Announces Health Canada Acceptance and Priority Review of New Drug Submission for Givinostat as a Duchenne Muscular Dystrophy Treatment

Indeterminate GlobeNewswire

Jun. 10, 2026

Italfarmaco annonce l’acceptation du dépôt et l’examen prioritaire par Santé Canada pour la présentation de drogue nouvelle du givinostat dans le traitement de la dystrophie musculaire de Duchenne

Indeterminate GlobeNewswire

Jun. 10, 2026

Reacta Healthcare Receives Extended MHRA Pharmaceutical Manufacturer’s Licence and GMP Certificate

Indeterminate GlobeNewswire

Jun. 10, 2026

Questex’s Fierce Biotech Expands Global Footprint, Launches Inaugural Fierce Biotech Event at London Life Sciences Week

Indeterminate GlobeNewswire

Jun. 10, 2026

CONNECTA Therapeutics Initiates Phase IIa Clinical Trial of CTH120, a First-in-Class Neuroplasticity Modulator, in Fragile X Syndrome

Indeterminate GlobeNewswire

Jun. 10, 2026

China-Singapore Tianjin Eco-City Builds Urban "Natural Oxygen Bar"

Indeterminate GlobeNewswire

Jun. 10, 2026

Cytospire Therapeutics Appoints Samit Hirawat, M.D., as Non-Executive Director

Indeterminate GlobeNewswire

Jun. 10, 2026

Imprivata, leader nelle soluzioni di gestione degli accessi, entra nel mercato italiano per supportare le organizzazioni sanitarie a migliorare la sicurezza senza rallentare la produttività

Indeterminate GlobeNewswire

Jun. 10, 2026

Nxera Joins OpenFold AI Research Consortium Alongside Leading Global Pharmaceutical and AI Companies to Accelerate AI-enabled Drug Discovery

Indeterminate GlobeNewswire

Jun. 10, 2026

Vara receives CE mark for tomosynthesis AI - extending Europe’s leading screening-grade AI portfolio to 3D

Indeterminate GlobeNewswire

Jun. 10, 2026

Ingredion annonce une offre publique recommandée d’acquisition de Tate & Lyle intégralement en numéraire

Indeterminate GlobeNewswire

Jun. 10, 2026

Press Release: Sanofi provides update on MOBILIZE phase 3 study of riliprubart in chronic inflammatory demyelinating polyneuropathy

Indeterminate GlobeNewswire